跳至主要内容
临床试验/CTRI/2024/11/076410
CTRI/2024/11/076410尚未招募不适用

A clinical study to evaluate and compare the effect of Trayodashanga Guggulu and Svayambhuva Guggulu with Laksha Guggulu along with Panchatiktaksheerabasti in the management of Asthikshaya.

Dr Sharanamma2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年11月20日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
120
试验地点
2
主要终点
To Know the effects of intervention on BMD t score and Laxana of Asthikshaya

研究概览

简要总结

Asthikshaya is Explained in Astadasha Kshaya by Acharya Charaka. Asthikshaya symptoms described in different Samhita are Asthibheda,Asthishoola, Kesha, loma,nakha, smashrudanta vikara, Sandhishaithilya and rukshata. As explaination of Asthikshaya is Analogous with description of Osteopenia and Osteoporosis in contemporary science and often reffered as the Silent Disease. It is considered as serious disabling disease of public health concer. Osteoporosis is disease the second most common metabolic bone and aslo degenerative disease that leads to an increased risk of fractures,but only a small proportion are diagnosed and treated. Modern drugs used for the treatment and have serious adverse effects.Hence there is a need of better and safe cost effective management of Asthikshaya, thus Study is "A CLINICALl STUDY TO EVALUATE AND COMPARE THE EFFECT  OF TRAYODASHANGA GUGGULU  AND SVAYAMBHUVA GUGGULU WITH  LAKSHA GUGGULU ALONG WITH  PANCHATIKTAKSHEERABASTI IN THE MANAGEMENT OG ASTHIKSHAYA."

HYPOTHESIS- Total no of subject..........120

Group A....(Lakshaguggulu with Panchatiktaksheerabasti) 40 subjects

Group B....( Trayodashangaguggulu with Panchatiktaksheerabasti) 40 subjects

Group c.....( svayambhuvaguggulu with Panchatiktaksheerabasti ) 40 subjects

Null Hypothesis - H0 - Group B and Group C are not having significant effect than Group A

Alternative Hypothesis-H1- Group B and Group C are having significant effect than Group A

Alternative Hypothesis- H2- Group B has Significant effect more than Group A

Alternative Hypothesis-H3- Group C has Significant effect more than the Group A.

VALUES.. 40+40+40= 120 is the Subjective values in the study.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • •Subjects complaining of classical symptoms of Asthikshaya- Asthishoola,Sandhishoola, Keshapatana, Dantavikara,Nakhavikara and Osteoporosis-Backpain,Jointpain will be included.
  • •Subjects between the age group of 40-70years of either sex.
  • •Subjects of Osteopenia and Osteoporosis diagnosed by Bone Mineral Density test.
  • •Subjects with BMD score below -1(minus).
  • •Subjects fit for Basti Karma.(scheduled treatment protocol).

排除标准

  • •Subjects associated with Hypertension, Diabetic mellitus and other systemic disorders.
  • •Subjects associated with Secondary Osteoporosis.
  • •Pregnant women and lactating women.
  • •Subjects with one or more fragility fracture.

结局指标

主要结局

To Know the effects of intervention on BMD t score and Laxana of Asthikshaya

时间窗: base line -36th day-66th day-96th day

次要结局

  • To evaluate if the Asthikshaya condition is reversible based on subject parameters like Asthishoola,sandhishoola,keshapatana,nakhadantapatana through Bastikarma & Shamanoushadhi.(To standardize the safe & effective ayurvedic line of management in asthikshaya in comparison to established drug in contemporary medicine based on subject parameters like Asthishoola,sandhishoola,keshapatana,nakhadantapatana.)

研究者

发起方
Dr Sharanamma
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sharanamma

Shri DGM Ayurvedic Medical College and Hospital Gadag

研究点 (2)

Loading locations...

相似试验